You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Retina Atrophy

Showing 1 - 25 of 2,083
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gyrate Atrophy Ocular and Systemic Study

Not yet recruiting
  • Gyrate Atrophy
  • +4 more
    • (no location specified)
    Jul 25, 2022

    Geographic Atrophy Trial in Bellaire, Dallas (OCU410)

    Recruiting
    • Geographic Atrophy
    • OCU410
    • Bellaire, Texas
    • +1 more
    Aug 25, 2023

    Geographic Atrophy of the Macula, Macular Degeneration Trial in United States (AVD-104, Sham injection)

    Not yet recruiting
    • Geographic Atrophy of the Macula
    • Macular Degeneration
    • Saint Petersburg, Florida
    • +4 more
    Apr 20, 2023

    Geographic Atrophy, Macular Degeneration Trial in United States (JNJ-81201887, Prednisone, Placebo)

    Recruiting
    • Geographic Atrophy
    • Macular Degeneration
    • Phoenix, Arizona
    • +3 more
    Mar 31, 2023

    Geographic Atrophy Trial in United States (RO7303359)

    Active, not recruiting
    • Geographic Atrophy
    • Encino, California
    • +12 more
    Dec 12, 2022

    Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa Trial in Westport, Coral Springs, Dubai (Arm 1)

    Recruiting
    • Retinal Disease
    • +17 more
    • Arm 1
    • Westport, Connecticut
    • +2 more
    Nov 25, 2022

    Geographic Atrophy Trial in United States (ORACEA®, Placebo)

    Completed
    • Geographic Atrophy
    • Glendale, California
    • +36 more
    Nov 3, 2022

    Macular Degeneration, Age-Related, Geographic Atrophy Trial in United States (FHTR2163)

    Terminated
    • Macular Degeneration, Age-Related
    • Geographic Atrophy
    • Bakersfield, California
    • +51 more
    Nov 22, 2022

    Macular Degeneration Trial in United Kingdom, United States (BI 754132)

    Terminated
    • Macular Degeneration
    • BI 754132
    • Beverly Hills, California
    • +12 more
    Aug 23, 2022

    Geographic Atrophy Trial in United States (PEGCETACOPLAN (APL-2))

    Completed
    • Geographic Atrophy
    • PEGCETACOPLAN (APL-2)
    • Bakersfield, California
    • +4 more
    Nov 8, 2021

    Age-related Macular Degeneration, Geographic Atrophy Trial (VOY-101)

    Recruiting
    • Age-related Macular Degeneration
    • Geographic Atrophy
    • VOY-101
    • Bellaire, Texas
      Retina Consultants of Texas
    Nov 17, 2022

    Macular Degeneration, Geographic Atrophy Trial in Worldwide (IONIS-FB-LRx, Placebo)

    Recruiting
    • Macular Degeneration
    • Geographic Atrophy
    • Phoenix, Arizona
    • +83 more
    Aug 19, 2022

    Geographic Atrophy, Macular Degeneration Trial in Dallas (Avacincaptad pegol 2 mg intravitreal injection)

    Not yet recruiting
    • Geographic Atrophy
    • Macular Degeneration
    • Avacincaptad pegol 2 mg intravitreal injection
    • Dallas, Texas
      Retina Foundation of the Southwest
    Sep 7, 2022

    Dry Age-related Macular Degeneration Trial in Worldwide (GT005: Medium Dose, GT005: High Dose)

    Active, not recruiting
    • Dry Age-related Macular Degeneration
    • GT005: Medium Dose
    • GT005: High Dose
    • Phoenix, Arizona
    • +61 more
    Dec 14, 2022

    Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)

    Terminated
    • Dry Age-related Macular Degeneration
    • +4 more
    • Phoenix, Arizona
    • +28 more
    Mar 22, 2022

    Age-Related Maculopathy, Age-Related Maculopathies, Eye Diseases Trial in United States (RN6G, Placebo)

    Completed
    Has Results
    • Age-Related Maculopathy
    • +4 more
    • RN6G
    • Placebo
    • Campbell, California
    • +23 more
    May 10, 2022

    Age-Related Macular Degeneration, Dry Age-related Macular Degeneration, Nonexudative Age-related Macular Degeneration Trial in

    Recruiting
    • Age-Related Macular Degeneration
    • +2 more
    • i-Lumen(TM) AMD
    • i-Lumen(TM) AMD Sham
    • Phoenix, Arizona
    • +2 more
    Sep 1, 2022

    Geographic Atrophy Trial in Worldwide (APL-2, Sham Procedure)

    Active, not recruiting
    • Geographic Atrophy
    • Phoenix, Arizona
    • +111 more
    Jun 20, 2022

    Geographic Atrophy Trial in Worldwide (APL-2, Sham Procedure)

    Active, not recruiting
    • Geographic Atrophy
    • Phoenix, Arizona
    • +140 more
    Jun 20, 2022

    Dry Age-related Macular Degeneration, Macular Degeneration, Retinal Disease Trial in United Kingdom, United States (GT005)

    Recruiting
    • Dry Age-related Macular Degeneration
    • +6 more
    • GT005
    • Saint Petersburg, Florida
    • +12 more
    Dec 21, 2021

    Geographic Atrophy Trial in United States (NGM621, Sham Comparator)

    Active, not recruiting
    • Geographic Atrophy
    • NGM621
    • Sham Comparator
    • Phoenix, Arizona
    • +64 more
    Aug 19, 2021

    Macular Degeneration, Senile, Laser Burn of Retina, Macular Degeneration Intermediate Trial in Genova, Milan, Rome (Pascal

    Recruiting
    • Macular Degeneration, Senile
    • +3 more
    • Pascal Synthesis 577 sub-threshold laser (Topcon Corporation, Tokyo, Japan)
    • Pascal Synthesis 577 sham (Topcon Corporation, Tokyo, Japan)
    • Genova, Italy
    • +3 more
    Jul 27, 2022

    Age-Related Macular Degeneration, Geographic Atrophy Trial in United States (smaller incision, new generation implantable

    Recruiting
    • Age-Related Macular Degeneration
    • Geographic Atrophy
    • smaller incision, new generation implantable miniature telescope (SING-IMT)
    • Pasadena, California
    • +7 more
    Aug 5, 2022

    Dry Age-related Macular Degeneration Trial in Worldwide (GT005; Low Dose, GT005; High Dose)

    Recruiting
    • Dry Age-related Macular Degeneration
    • GT005; Low Dose
    • GT005; High Dose
    • Palo Alto, California
    • +28 more
    Dec 1, 2021

    Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)

    Completed
    • Dry Age-related Macular Degeneration
    • +4 more
    • GEM103
    • Phoenix, Arizona
    • +11 more
    Feb 9, 2021